Safety Information on the use of blue dye Patent Blue V
The MHRA
have provided the ABS with a communication for healthcare
professionals regarding serious allergic reactions associated with
Patent Blue V.
To read the
letter please click
here
Following
advice from the Pharmacovigilance Expert Advisory Group in November
2011 on this issue, the MHRA have initiated several lines
of communications to Healthcare Professionals, including a Drug
Safety Article (published Feb 2012) and a Dear Pharmacist letter
which will be included in Patent Blue V packaging and also sent to
Pharmacists who previously ordered the product (commencing Feb
2012).